ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
10.96
-0.01 (-0.09%)
Nov 20, 2024, 4:00 PM EST - Market closed
ClearPoint Neuro Market Cap
ClearPoint Neuro has a market cap or net worth of $302.33 million as of November 21, 2024. Its market cap has increased by 104.14% in one year.
Market Cap
302.33M
Enterprise Value
284.45M
1-Year Change
104.14%
Ranking
Category
Stock Price
$10.96
Market Cap Chart
Since May 22, 2012, ClearPoint Neuro's market cap has increased from $30.30M to $302.33M, an increase of 897.78%. That is a compound annual growth rate of 20.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 302.60M | 80.98% |
| Dec 29, 2023 | 167.20M | -19.62% |
| Dec 30, 2022 | 208.00M | -21.57% |
| Dec 31, 2021 | 265.20M | -1.08% |
| Dec 31, 2020 | 268.10M | 267.26% |
| Dec 31, 2019 | 73.00M | 337.13% |
| Dec 31, 2018 | 16.70M | -41.61% |
| Dec 29, 2017 | 28.60M | 132.52% |
| Dec 30, 2016 | 12.30M | -56.84% |
| Dec 31, 2015 | 28.50M | -41.84% |
| Dec 31, 2014 | 49.00M | -42.22% |
| Dec 31, 2013 | 84.80M | 10.42% |
| Dec 31, 2012 | 76.80M | 153.47% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 310.38M |
| Design Therapeutics | 310.28M |
| Lyell Immunopharma | 309.93M |
| Nyxoah | 309.60M |
| Immutep | 303.61M |
| Sage Therapeutics | 300.36M |
| Kodiak Sciences | 296.11M |
| Aldeyra Therapeutics | 294.18M |